News Focus
News Focus
icon url

misiu143

05/10/21 8:17 AM

#164577 RE: stockorus #164576

Maybe they will not talk separately about first 28 patients .

I am actually satisfy when I heard dr Randy saying during one of his resent interview that so far results with Leronlimab are
“dramatic “
And they have many more then 28 patients already ..

And we know that if doctors will not see positive results they will not fight to get a drug .
I see that doctors in Philippines are more independent that in USA when some still don’t want to order leronlimab when family is asking for it .

Imo ..

icon url

DonDonDonDon

05/10/21 11:59 PM

#164644 RE: stockorus #164576

Also, as someone else mentioned, what happened to the 28 CSP patients? Why no mention of this?


38% of critical patients who received leronlimab in the trial passed away within 28 days. If 11 of the 28 original Filipino patients passed away, that is the kind of news that CytoDyn keeps secret. Just like the severe patients in the CD12. Severe patients represent 5/6ths of the trial and we know absolutely nothing about their data.

HGEN has already released a preprint for their trial. HGEN's trial finished a month after leronlimab's CD12 trial. But then again, we are still waiting on the leronlimab's M2M trial data that finished last summer.